Thiazolidinedione [EPC]

Thiazolidinedione [EPC] was reported 9769 times

Drugs of the Thiazolidinedione [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MALIGNANT SPINAL CORD COMPRESSION 19 0.4524
1 MENINGITIS EOSINOPHILIC 6 0.2000
2 BLADDER TRABECULATION 6 0.0741
3 NECROTISING OESOPHAGITIS 22 0.0441
4 LIPOMATOSIS 8 0.0404
5 CAPILLARITIS 11 0.0399
6 PORTAL FIBROSIS 8 0.0374
7 DIABETIC METABOLIC DECOMPENSATION 44 0.0317
8 SCROTAL ABSCESS 9 0.0238
9 BIOPSY SKIN ABNORMAL 5 0.0208
10 TOTAL LUNG CAPACITY ABNORMAL 8 0.0206
11 HYPERINSULINAEMIA 6 0.0196
12 INSULIN AUTOIMMUNE SYNDROME 7 0.0196
13 GENITAL INFECTION FUNGAL 15 0.0182
14 MITE ALLERGY 11 0.0168
15 PULMONARY VASCULITIS 9 0.0167
16 POSTMORTEM BLOOD DRUG LEVEL INCREASED 6 0.0161
17 BLADDER TRANSITIONAL CELL CARCINOMA 23 0.0161
18 SPIROMETRY ABNORMAL 9 0.0151
19 URETERIC CANCER 6 0.0150
20 GENITAL ABSCESS 6 0.0149
21 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 10 0.0136
22 PERINEAL ABSCESS 6 0.0133
23 MYCOTIC ALLERGY 11 0.0129
24 GASTROINTESTINAL HYPOMOTILITY 28 0.0124
25 EUGLYCAEMIC DIABETIC KETOACIDOSIS 51 0.0123
26 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 13 0.0122
27 BLADDER MASS 6 0.0121
28 ACIDOSIS HYPERCHLORAEMIC 7 0.0118
29 GINGIVAL HYPERPLASIA 7 0.0117
30 HYPERPARATHYROIDISM SECONDARY 29 0.0116
31 ANTIPSYCHOTIC DRUG LEVEL DECREASED 6 0.0113
32 NEPHROGENIC ANAEMIA 50 0.0108
33 BLADDER NEOPLASM 18 0.0105
34 DUST ALLERGY 10 0.0102
35 REBOUND ACID HYPERSECRETION 26 0.0086
36 SCROTAL OEDEMA 6 0.0084
37 CAMPYLOBACTER GASTROENTERITIS 5 0.0084
38 MICROALBUMINURIA 6 0.0079
39 IMPAIRED GASTRIC EMPTYING 108 0.0079
40 NEURITIS 12 0.0078
41 BLOOD KETONE BODY INCREASED 6 0.0077
42 CONJUNCTIVITIS ALLERGIC 11 0.0074
43 IIIRD NERVE PARALYSIS 6 0.0074
44 KETOSIS 8 0.0074
45 VESTIBULAR DISORDER 9 0.0073
46 PERIRECTAL ABSCESS 8 0.0072
47 DIVERTICULAR PERFORATION 14 0.0068
48 UPPER AIRWAY OBSTRUCTION 6 0.0068
49 COAGULATION TIME PROLONGED 10 0.0065
50 COVID-19 IMMUNISATION 5 0.0060
51 DIABETES MELLITUS INADEQUATE CONTROL 98 0.0055
52 KIDNEY ENLARGEMENT 6 0.0055
53 TRANSITIONAL CELL CARCINOMA 7 0.0054
54 INFECTIOUS MONONUCLEOSIS 12 0.0053
55 INSULIN RESISTANCE 11 0.0053
56 NEOPLASM SKIN 8 0.0051
57 INCISION SITE PAIN 6 0.0051
58 HIGH DENSITY LIPOPROTEIN DECREASED 17 0.0051
59 DIABETIC KETOACIDOSIS 120 0.0050
60 OPHTHALMIC HERPES ZOSTER 9 0.0050
61 GLYCOSYLATED HAEMOGLOBIN DECREASED 8 0.0050
62 HYPOGLYCAEMIA 240 0.0049
63 PANCREATIC CARCINOMA METASTATIC 14 0.0049
64 ESSENTIAL HYPERTENSION 9 0.0049
65 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 10 0.0049
66 INVESTIGATION ABNORMAL 7 0.0049
67 GLYCOSYLATED HAEMOGLOBIN INCREASED 118 0.0047
68 PANCREATITIS CHRONIC 11 0.0046
69 RENAL TUBULAR ACIDOSIS 10 0.0046
70 NECROTISING FASCIITIS 16 0.0045
71 DISTRIBUTIVE SHOCK 10 0.0044
72 METABOLIC ALKALOSIS 7 0.0044
73 SLEEP TALKING 7 0.0041
74 FAECAL CALPROTECTIN INCREASED 13 0.0041
75 BLOOD PH DECREASED 7 0.0041
76 BLOOD ELECTROLYTES ABNORMAL 5 0.0040
77 KIDNEY FIBROSIS 7 0.0040
78 END STAGE RENAL DISEASE 73 0.0040
79 PEMPHIGOID 30 0.0040
80 PERIARTHRITIS 9 0.0040
81 ADENOCARCINOMA PANCREAS 5 0.0039
82 DIABETIC NEUROPATHY 19 0.0038
83 FIBULA FRACTURE 11 0.0038
84 HYPOGLYCAEMIC COMA 11 0.0038
85 AORTIC STENOSIS 13 0.0037
86 NORMOCHROMIC NORMOCYTIC ANAEMIA 11 0.0037
87 INTENTIONAL DEVICE MISUSE 16 0.0036
88 EARLY SATIETY 7 0.0036
89 LEFT VENTRICULAR DYSFUNCTION 24 0.0036
90 FORCED EXPIRATORY VOLUME DECREASED 10 0.0035
91 LEFT VENTRICULAR HYPERTROPHY 15 0.0035
92 EYELID DISORDER 8 0.0035
93 RENAL TUBULAR NECROSIS 34 0.0035
94 HYPERLACTACIDAEMIA 9 0.0034
95 LACTIC ACIDOSIS 108 0.0033
96 CHRONIC KIDNEY DISEASE 248 0.0033
97 DIASTOLIC DYSFUNCTION 10 0.0032
98 DIABETIC RETINOPATHY 11 0.0032
99 HYPERGLYCAEMIA 116 0.0032
100 DIABETIC NEPHROPATHY 7 0.0032
101 EXPOSURE VIA INGESTION 8 0.0032
102 RESPIRATORY SYMPTOM 9 0.0032
103 GALLBLADDER INJURY 6 0.0031
104 HYPERTHYROIDISM 44 0.0030
105 CONTRAINDICATED PRODUCT PRESCRIBED 5 0.0030
106 GASTROINTESTINAL INJURY 8 0.0030
107 URINE FLOW DECREASED 7 0.0029
108 RADIUS FRACTURE 7 0.0029
109 ARTERIOSCLEROSIS 27 0.0029
110 ARTERIOSCLEROSIS CORONARY ARTERY 19 0.0029
111 INFLAMMATORY BOWEL DISEASE 28 0.0029
112 HYPOPHOSPHATAEMIA 21 0.0028
113 JAUNDICE CHOLESTATIC 10 0.0028
114 HEART DISEASE CONGENITAL 10 0.0028
115 VULVOVAGINAL MYCOTIC INFECTION 11 0.0028
116 POLYDIPSIA 11 0.0028
117 TIBIA FRACTURE 13 0.0028
118 ATRIOVENTRICULAR BLOCK FIRST DEGREE 12 0.0028
119 TOXIC ENCEPHALOPATHY 14 0.0028
120 OESOPHAGEAL CANDIDIASIS 11 0.0028
121 FEMORAL NECK FRACTURE 14 0.0027
122 HYPOMAGNESAEMIA 38 0.0027
123 BLOOD GLUCOSE ABNORMAL 50 0.0027
124 THORACIC VERTEBRAL FRACTURE 8 0.0027
125 HALLUCINATION, VISUAL 57 0.0027
126 HYDRONEPHROSIS 20 0.0027
127 BLOOD LOSS ANAEMIA 6 0.0026
128 YAWNING 7 0.0026
129 DIZZINESS POSTURAL 25 0.0026
130 BLOOD GLUCOSE FLUCTUATION 28 0.0026
131 CARDIAC FAILURE ACUTE 17 0.0025
132 HAEMATURIA 87 0.0025
133 CARDIAC TAMPONADE 12 0.0025
134 ONYCHOMYCOSIS 11 0.0025
135 SHOCK 57 0.0025
136 METABOLIC ACIDOSIS 79 0.0025
137 LIVER ABSCESS 8 0.0025
138 HYPERTONIC BLADDER 7 0.0024
139 CHOLANGITIS 15 0.0024
140 ABDOMINAL HERNIA 11 0.0024
141 TYPE 2 DIABETES MELLITUS 80 0.0024
142 AORTIC ARTERIOSCLEROSIS 6 0.0023
143 BLOOD GLUCOSE DECREASED 111 0.0023
144 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
145 KETOACIDOSIS 17 0.0023
146 BRAIN NATRIURETIC PEPTIDE INCREASED 7 0.0023
147 PANCREATIC DISORDER 11 0.0022
148 ANORGASMIA 6 0.0022
149 ACUTE KIDNEY INJURY 333 0.0022
150 PULMONARY ALVEOLAR HAEMORRHAGE 12 0.0021
151 SUSPECTED SUICIDE 10 0.0021
152 MYOSITIS 19 0.0021
153 NEUROLOGICAL SYMPTOM 12 0.0021
154 ABNORMAL LOSS OF WEIGHT 14 0.0021
155 BLOOD GLUCOSE INCREASED 384 0.0020
156 RENAL INJURY 60 0.0020
157 METABOLIC ENCEPHALOPATHY 6 0.0020
158 INTESTINAL ISCHAEMIA 11 0.0020
159 OEDEMA 106 0.0020
160 HYPERURICAEMIA 8 0.0019
161 NEUTROPHILIA 11 0.0019
162 HALLUCINATIONS, MIXED 8 0.0019
163 FACE OEDEMA 32 0.0019
164 URINE ODOUR ABNORMAL 11 0.0019
165 BLADDER CANCER 110 0.0019
166 UNRESPONSIVE TO STIMULI 48 0.0019
167 GINGIVITIS 10 0.0019
168 URINE OUTPUT DECREASED 16 0.0018
169 CLAVICLE FRACTURE 7 0.0018
170 CHOLECYSTITIS INFECTIVE 5 0.0018
171 ILEUS 22 0.0018
172 CARDIAC FAILURE 142 0.0018
173 CERVICAL VERTEBRAL FRACTURE 6 0.0017
174 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
175 LOCALISED OEDEMA 8 0.0017
176 BLOOD POTASSIUM INCREASED 28 0.0017
177 SALIVARY HYPERSECRETION 17 0.0017
178 TACHYPNOEA 23 0.0017
179 GASTROINTESTINAL MOTILITY DISORDER 9 0.0017
180 CREPITATIONS 5 0.0017
181 HYPERLIPIDAEMIA 20 0.0017
182 NOCTURIA 20 0.0016
183 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
184 AORTIC VALVE INCOMPETENCE 7 0.0016
185 CARDIAC FAILURE CHRONIC 7 0.0016
186 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
187 CHOKING SENSATION 9 0.0016
188 PARADOXICAL DRUG REACTION 6 0.0016
189 ACUTE MYOCARDIAL INFARCTION 48 0.0016
190 RENAL FAILURE 216 0.0016
191 BLOOD MAGNESIUM DECREASED 14 0.0016
192 ANKLE FRACTURE 25 0.0016
193 NODULE 21 0.0016
194 NEPHROPATHY 15 0.0016
195 CHOLECYSTITIS 19 0.0016
196 POLYURIA 13 0.0016
197 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
198 PLEURAL EFFUSION 95 0.0016
199 ANAL INCONTINENCE 14 0.0016
200 TUBULOINTERSTITIAL NEPHRITIS 29 0.0015
201 CARDIOMEGALY 19 0.0015
202 INJECTION SITE EXTRAVASATION 19 0.0015
203 LUMBAR VERTEBRAL FRACTURE 7 0.0015
204 POISONING 19 0.0015
205 CEREBRAL ATROPHY 6 0.0015
206 HYPERKALAEMIA 52 0.0015
207 GALLBLADDER OPERATION 6 0.0015
208 CARDIAC FAILURE CONGESTIVE 119 0.0015
209 RENAL IMPAIRMENT 124 0.0015
210 BLOOD CREATINE PHOSPHOKINASE INCREASED 42 0.0015
211 OEDEMA PERIPHERAL 177 0.0015
212 HUMERUS FRACTURE 7 0.0015
213 HYPERKERATOSIS 8 0.0014
214 OLIGURIA 9 0.0014
215 HEPATIC STEATOSIS 27 0.0014
216 FLUID OVERLOAD 21 0.0014
217 RENAL CELL CARCINOMA 7 0.0014
218 RENAL FAILURE CHRONIC 11 0.0014
219 DIABETES MELLITUS 109 0.0014
220 TONGUE DISCOMFORT 6 0.0014
221 ABSCESS LIMB 6 0.0014
222 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
223 STAPHYLOCOCCAL BACTERAEMIA 6 0.0014
224 COMPLETED SUICIDE 115 0.0014
225 HAEMATOTOXICITY 13 0.0014
226 TUMOUR LYSIS SYNDROME 12 0.0014
227 HYPOXIA 48 0.0014
228 PANCREATITIS 72 0.0014
229 PERIPHERAL VASCULAR DISORDER 7 0.0014
230 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
231 INTENTIONAL OVERDOSE 86 0.0013
232 PULMONARY OEDEMA 60 0.0013
233 FLUID RETENTION 68 0.0013
234 METASTASES TO LYMPH NODES 9 0.0013
235 HYPOPHAGIA 34 0.0013
236 GANGRENE 8 0.0013
237 DEHYDRATION 177 0.0013
238 FULL BLOOD COUNT ABNORMAL 14 0.0013
239 HAEMOGLOBIN INCREASED 6 0.0013
240 HAEMODIALYSIS 11 0.0013
241 ISCHAEMIA 6 0.0013
242 BLOOD POTASSIUM DECREASED 39 0.0013
243 GENERALISED OEDEMA 16 0.0013
244 THIRST 23 0.0013
245 PSYCHOLOGICAL TRAUMA 11 0.0013
246 DEAFNESS UNILATERAL 7 0.0013
247 SKIN ABRASION 6 0.0013
248 PYELONEPHRITIS 11 0.0013
249 ORTHOSTATIC HYPOTENSION 22 0.0013
250 PRODUCT SUPPLY ISSUE 9 0.0013
251 ERUCTATION 24 0.0012
252 SCRATCH 13 0.0012
253 HEPATITIS ACUTE 8 0.0012
254 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
255 RENAL FAILURE ACUTE 52 0.0012
256 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
257 SPINAL COMPRESSION FRACTURE 10 0.0012
258 METABOLIC DISORDER 7 0.0012
259 ELECTROLYTE IMBALANCE 14 0.0012
260 PANCREATITIS ACUTE 27 0.0012
261 FLUID INTAKE REDUCED 6 0.0012
262 HYPERTRIGLYCERIDAEMIA 7 0.0012
263 NERVE COMPRESSION 11 0.0012
264 IRON DEFICIENCY ANAEMIA 11 0.0012
265 BREAST MASS 8 0.0012
266 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
267 INJECTION SITE NODULE 13 0.0012
268 NEUROLEPTIC MALIGNANT SYNDROME 14 0.0012
269 CATARACT OPERATION 7 0.0012
270 HYPONATRAEMIA 66 0.0012
271 CONCUSSION 9 0.0012
272 MALNUTRITION 13 0.0012
273 ANURIA 10 0.0012
274 VENTRICULAR EXTRASYSTOLES 12 0.0012
275 TENDERNESS 12 0.0012
276 RHABDOMYOLYSIS 48 0.0011
277 AUTOIMMUNE HEPATITIS 8 0.0011
278 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
279 AFFECTIVE DISORDER 9 0.0011
280 NYSTAGMUS 6 0.0011
281 VITAMIN D DEFICIENCY 11 0.0011
282 SINUS TACHYCARDIA 16 0.0011
283 EYE HAEMORRHAGE 15 0.0011
284 COMPRESSION FRACTURE 6 0.0011
285 HEPATIC CIRRHOSIS 21 0.0011
286 TREATMENT NONCOMPLIANCE 61 0.0011
287 HOSPICE CARE 11 0.0011
288 GAIT INABILITY 37 0.0011
289 DECREASED APPETITE 256 0.0011
290 LIVER FUNCTION TEST ABNORMAL 32 0.0011
291 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
292 PULMONARY FIBROSIS 21 0.0011
293 SEROTONIN SYNDROME 21 0.0011
294 CONSTIPATION 237 0.0011
295 ACUTE CORONARY SYNDROME 9 0.0011
296 FEEDING DISORDER 22 0.0011
297 GASTRIC ULCER HAEMORRHAGE 6 0.0011
298 PERICARDIAL EFFUSION 25 0.0011
299 ARTHRITIS INFECTIVE 5 0.0011
300 HUNGER 15 0.0011
301 CELLULITIS 54 0.0011
302 PERIPHERAL SWELLING 165 0.0011
303 WHITE BLOOD CELL COUNT INCREASED 41 0.0011
304 CEREBRAL INFARCTION 26 0.0011
305 POOR VENOUS ACCESS 11 0.0011
306 PULMONARY CONGESTION 14 0.0011
307 MITRAL VALVE INCOMPETENCE 12 0.0011
308 POLLAKIURIA 44 0.0011
309 PETECHIAE 11 0.0011
310 RESPIRATORY ARREST 29 0.0011
311 HAEMODYNAMIC INSTABILITY 8 0.0010
312 SPINAL FRACTURE 21 0.0010
313 BOWEL MOVEMENT IRREGULARITY 8 0.0010
314 CORONARY ARTERY BYPASS 6 0.0010
315 EXERCISE TOLERANCE DECREASED 6 0.0010
316 MOUTH SWELLING 6 0.0010
317 DYSPNOEA EXERTIONAL 39 0.0010
318 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
319 INJECTION SITE MASS 38 0.0010
320 CORONARY ARTERY OCCLUSION 14 0.0010
321 ARTERIAL OCCLUSIVE DISEASE 8 0.0010
322 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
323 CARDIOMYOPATHY 15 0.0010
324 BREATH SOUNDS ABNORMAL 5 0.0010
325 ERECTILE DYSFUNCTION 26 0.0010
326 ODYNOPHAGIA 6 0.0010
327 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 17 0.0010
328 GASTROENTERITIS VIRAL 18 0.0010
329 WHITE BLOOD CELL COUNT DECREASED 108 0.0010
330 TYPE 1 DIABETES MELLITUS 6 0.0010
331 CORONARY ARTERY STENOSIS 5 0.0010
332 LETHARGY 57 0.0010
333 MYASTHENIA GRAVIS 8 0.0010
334 ECONOMIC PROBLEM 15 0.0010
335 OBSTRUCTIVE AIRWAYS DISORDER 11 0.0010
336 SCHIZOPHRENIA 12 0.0010
337 PNEUMONIA BACTERIAL 9 0.0010
338 BRADYCARDIA 52 0.0010
339 MENISCUS INJURY 6 0.0010
340 UROSEPSIS 9 0.0010
341 SMALL INTESTINAL OBSTRUCTION 12 0.0010
342 EYE PAIN 55 0.0010
343 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
344 HAEMORRHOIDS 19 0.0010
345 ABNORMAL WEIGHT GAIN 12 0.0010
346 DRUG INTERACTION 154 0.0010
347 WEIGHT INCREASED 217 0.0010
348 FALL 319 0.0010
349 MELAENA 21 0.0010
350 MULTIPLE INJURIES 6 0.0010
351 CANDIDA INFECTION 16 0.0009
352 GLAUCOMA 18 0.0009
353 COVID-19 PNEUMONIA 11 0.0009
354 INTESTINAL OBSTRUCTION 35 0.0009
355 SWOLLEN TONGUE 29 0.0009
356 ANAL ABSCESS 5 0.0009
357 DRUG-INDUCED LIVER INJURY 29 0.0009
358 MUSCULAR WEAKNESS 105 0.0009
359 WEIGHT DECREASED 256 0.0009
360 ACIDOSIS 7 0.0009
361 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
362 BODY TEMPERATURE DECREASED 9 0.0009
363 LIPASE INCREASED 7 0.0009
364 INTERNATIONAL NORMALISED RATIO INCREASED 26 0.0009
365 GROIN PAIN 8 0.0009
366 SPINAL OSTEOARTHRITIS 8 0.0009
367 ANGINA PECTORIS 26 0.0009
368 HAEMATEMESIS 23 0.0009
369 INABILITY TO AFFORD MEDICATION 9 0.0009
370 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
371 IMPAIRED QUALITY OF LIFE 13 0.0009
372 ABDOMINAL PAIN UPPER 186 0.0009
373 ACCIDENTAL UNDERDOSE 13 0.0009
374 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
375 HIP FRACTURE 29 0.0009
376 RENAL DISORDER 42 0.0009
377 SKIN MASS 6 0.0009
378 DYSURIA 33 0.0009
379 BLOOD URINE PRESENT 17 0.0009
380 ORAL PAIN 20 0.0009
381 SPINAL OPERATION 11 0.0009
382 EMPHYSEMA 9 0.0009
383 GOUT 16 0.0009
384 LOSS OF LIBIDO 8 0.0009
385 COLITIS ISCHAEMIC 6 0.0009
386 POSTOPERATIVE WOUND INFECTION 6 0.0009
387 CHOLELITHIASIS 29 0.0009
388 DYSPEPSIA 87 0.0009
389 HAIR COLOUR CHANGES 11 0.0009
390 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
391 CHOLECYSTITIS ACUTE 5 0.0009
392 AGEUSIA 22 0.0009
393 DIARRHOEA 569 0.0009
394 TRICUSPID VALVE INCOMPETENCE 7 0.0009
395 PRESCRIBED OVERDOSE 17 0.0009
396 ATRIAL FLUTTER 7 0.0009
397 SKIN HAEMORRHAGE 13 0.0009
398 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
399 EYE MOVEMENT DISORDER 6 0.0009
400 MICTURITION URGENCY 10 0.0009
401 RIB FRACTURE 18 0.0009
402 GASTRITIS 23 0.0009
403 ATRIAL FIBRILLATION 85 0.0009
404 MYALGIA 148 0.0009
405 RHINITIS 7 0.0009
406 LARGE INTESTINE POLYP 6 0.0009
407 PANCREATIC CARCINOMA 25 0.0009
408 METASTASES TO LUNG 10 0.0009
409 HAEMOPTYSIS 24 0.0009
410 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
411 EXTRASYSTOLES 6 0.0009
412 HEAD INJURY 27 0.0009
413 INCONTINENCE 9 0.0009
414 VOMITING 399 0.0008
415 FLATULENCE 48 0.0008
416 DIVERTICULUM 6 0.0008
417 FULL BLOOD COUNT DECREASED 17 0.0008
418 BLOOD CREATININE INCREASED 55 0.0008
419 BODY HEIGHT DECREASED 9 0.0008
420 EJECTION FRACTION DECREASED 13 0.0008
421 SEPSIS 93 0.0008
422 THERAPY PARTIAL RESPONDER 13 0.0008
423 BASAL CELL CARCINOMA 13 0.0008
424 BALANCE DISORDER 72 0.0008
425 GASTROOESOPHAGEAL REFLUX DISEASE 67 0.0008
426 LEUKOCYTOSIS 15 0.0008
427 NEPHROLITHIASIS 38 0.0008
428 ANAEMIA 158 0.0008
429 OSTEOMYELITIS 15 0.0008
430 HOT FLUSH 62 0.0008
431 STAPHYLOCOCCAL INFECTION 27 0.0008
432 HALLUCINATION, AUDITORY 13 0.0008
433 GASTROINTESTINAL PAIN 9 0.0008
434 URINARY TRACT INFECTION 139 0.0008
435 BLINDNESS TRANSIENT 6 0.0008
436 PRODUCT DOSE OMISSION 53 0.0008
437 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
438 ABDOMINAL PAIN 188 0.0008
439 SINUS DISORDER 16 0.0008
440 FEELING DRUNK 6 0.0008
441 BLOOD PRESSURE ABNORMAL 16 0.0008
442 LOCAL SWELLING 14 0.0008
443 NEPHROPATHY TOXIC 9 0.0008
444 HYPOKALAEMIA 37 0.0008
445 PRODUCTIVE COUGH 38 0.0008
446 FRACTURE 15 0.0008
447 FOOT FRACTURE 15 0.0008
448 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
449 MYOCARDIAL ISCHAEMIA 9 0.0008
450 HEPATOCELLULAR CARCINOMA 6 0.0008
451 AORTIC ANEURYSM 6 0.0008
452 CYSTITIS 25 0.0008
453 INTERSTITIAL LUNG DISEASE 38 0.0008
454 INSURANCE ISSUE 12 0.0008
455 ACUTE RESPIRATORY FAILURE 15 0.0008
456 URINARY RETENTION 26 0.0008
457 ROTATOR CUFF SYNDROME 10 0.0008
458 DELIRIUM 27 0.0008
459 BLOOD UREA INCREASED 13 0.0008
460 VASCULITIS 9 0.0008
461 PELVIC FRACTURE 6 0.0008
462 ANGINA UNSTABLE 5 0.0008
463 HAEMORRHAGIC STROKE 6 0.0008
464 TORSADE DE POINTES 6 0.0008
465 TOOTH DISORDER 17 0.0008
466 BLOOD IRON DECREASED 9 0.0008
467 ATAXIA 9 0.0008
468 PNEUMOTHORAX 12 0.0008
469 RENAL CYST 6 0.0008
470 APPETITE DISORDER 5 0.0008
471 ACCIDENT 9 0.0008
472 OBESITY 12 0.0008
473 MIDDLE INSOMNIA 14 0.0007
474 CONFUSIONAL STATE 121 0.0007
475 ABDOMINAL DISTENSION 78 0.0007
476 ANGIOEDEMA 33 0.0007
477 JOINT RANGE OF MOTION DECREASED 10 0.0007
478 PRODUCT DOSE OMISSION IN ERROR 21 0.0007
479 HYPOTENSION 148 0.0007
480 ASTHENIA 277 0.0007
481 PROTEINURIA 14 0.0007
482 DECUBITUS ULCER 6 0.0007
483 ASPHYXIA 6 0.0007
484 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
485 ENCEPHALOPATHY 18 0.0007
486 INCREASED APPETITE 14 0.0007
487 GALLBLADDER DISORDER 13 0.0007
488 LACRIMATION INCREASED 22 0.0007
489 HAIR DISORDER 6 0.0007
490 NAUSEA 576 0.0007
491 ATELECTASIS 7 0.0007
492 PERITONITIS 15 0.0007
493 DENTAL CARIES 8 0.0007
494 TOOTH EXTRACTION 9 0.0007
495 DIVERTICULITIS 20 0.0007
496 PARKINSONISM 7 0.0007
497 HEART RATE DECREASED 25 0.0007
498 OXYGEN SATURATION DECREASED 40 0.0007
499 URINARY INCONTINENCE 21 0.0007
500 INFLUENZA 79 0.0007
501 SEASONAL ALLERGY 10 0.0007
502 HEPATITIS 18 0.0007
503 JOINT INJURY 15 0.0007
504 VITAMIN D DECREASED 6 0.0007
505 NEUTROPENIA 95 0.0007
506 SKIN ULCER 18 0.0007
507 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 49 0.0007
508 DRY THROAT 7 0.0007
509 CATARACT 41 0.0007
510 GASTROENTERITIS 10 0.0007
511 DYSSTASIA 20 0.0007
512 MENTAL STATUS CHANGES 19 0.0007
513 MEDICATION ERROR 38 0.0007
514 METASTASES TO LIVER 12 0.0007
515 SLEEP APNOEA SYNDROME 13 0.0007
516 ABDOMINAL DISCOMFORT 114 0.0007
517 LOWER LIMB FRACTURE 13 0.0007
518 BACK DISORDER 11 0.0007
519 LIVER DISORDER 30 0.0007
520 CEREBRAL DISORDER 5 0.0007
521 PULMONARY MASS 10 0.0007
522 HAEMOLYTIC ANAEMIA 6 0.0007
523 PRODUCT ODOUR ABNORMAL 7 0.0007
524 COVID-19 117 0.0007
525 CONTUSION 64 0.0007
526 CHROMATURIA 15 0.0007
527 URTICARIA 111 0.0007
528 LOCALISED INFECTION 16 0.0007
529 DIZZINESS 329 0.0007
530 HYPOTHYROIDISM 21 0.0007
531 UNDERDOSE 48 0.0007
532 PALPITATIONS 77 0.0007
533 RETCHING 14 0.0007
534 DEVICE MECHANICAL ISSUE 9 0.0007
535 PERIPHERAL COLDNESS 9 0.0007
536 PROSTATIC SPECIFIC ANTIGEN INCREASED 9 0.0007
537 DYSPNOEA 368 0.0006
538 ATRIOVENTRICULAR BLOCK 5 0.0006
539 DEVICE LEAKAGE 28 0.0006
540 HERPES ZOSTER 37 0.0006
541 BIPOLAR DISORDER 7 0.0006
542 SKIN LACERATION 7 0.0006
543 DELUSION 10 0.0006
544 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
545 SEPTIC SHOCK 28 0.0006
546 ERYTHEMA MULTIFORME 6 0.0006
547 MUSCLE SPASMS 118 0.0006
548 CARPAL TUNNEL SYNDROME 9 0.0006
549 GASTRIC DISORDER 22 0.0006
550 BLISTER 36 0.0006
551 DRY MOUTH 52 0.0006
552 OESOPHAGITIS 7 0.0006
553 PNEUMONIA ASPIRATION 16 0.0006
554 FLANK PAIN 6 0.0006
555 FATIGUE 495 0.0006
556 TOXICITY TO VARIOUS AGENTS 107 0.0006
557 GASTROINTESTINAL HAEMORRHAGE 53 0.0006
558 DYSGEUSIA 47 0.0006
559 FUNGAL INFECTION 21 0.0006
560 FEELING JITTERY 12 0.0006
561 PAIN IN EXTREMITY 185 0.0006
562 CORONARY ARTERY DISEASE 19 0.0006
563 INJECTION SITE HAEMORRHAGE 50 0.0006
564 PNEUMONITIS 17 0.0006
565 PARAESTHESIA ORAL 9 0.0006
566 OCULAR DISCOMFORT 7 0.0006
567 THERAPY NON-RESPONDER 28 0.0006
568 NIGHT SWEATS 20 0.0006
569 SWELLING 58 0.0006
570 PLATELET COUNT DECREASED 66 0.0006
571 PNEUMONIA 199 0.0006
572 BLINDNESS 25 0.0006
573 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 32 0.0006
574 FEELING COLD 17 0.0006
575 EATING DISORDER 13 0.0006
576 ABNORMAL FAECES 5 0.0006
577 KNEE OPERATION 6 0.0006
578 IMPAIRED WORK ABILITY 13 0.0006
579 VISION BLURRED 83 0.0006
580 DRUG LEVEL INCREASED 10 0.0006
581 BACK PAIN 140 0.0006
582 BLOOD PRESSURE DECREASED 40 0.0006
583 THERAPY INTERRUPTED 43 0.0006
584 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 14 0.0006
585 SYNCOPE 60 0.0006
586 MOBILITY DECREASED 43 0.0006
587 HAIR TEXTURE ABNORMAL 8 0.0006
588 INTENTIONAL DOSE OMISSION 17 0.0006
589 HYPERTENSION 126 0.0006
590 OSTEOPENIA 9 0.0006
591 HYPERSOMNIA 17 0.0006
592 PRODUCT TASTE ABNORMAL 8 0.0006
593 PRODUCT SUBSTITUTION ISSUE 34 0.0006
594 EYELID PTOSIS 6 0.0006
595 HEPATIC FUNCTION ABNORMAL 22 0.0006
596 LIMB INJURY 16 0.0006
597 SLUGGISHNESS 6 0.0006
598 NEUTROPHIL COUNT INCREASED 6 0.0006
599 LOSS OF CONSCIOUSNESS 75 0.0006
600 ARTHRITIS 46 0.0006
601 BLOOD SODIUM DECREASED 11 0.0006
602 CHEST PAIN 108 0.0006
603 CARDIAC OPERATION 5 0.0006
604 EYE DISCHARGE 6 0.0006
605 SUICIDE ATTEMPT 35 0.0006
606 ROAD TRAFFIC ACCIDENT 24 0.0006
607 WEIGHT FLUCTUATION 6 0.0006
608 APHONIA 8 0.0006
609 TRANSFUSION 6 0.0006
610 ANHEDONIA 15 0.0006
611 BLOOD CALCIUM INCREASED 5 0.0006
612 BRONCHITIS 42 0.0006
613 HYPERCALCAEMIA 7 0.0006
614 SLEEP DISORDER 40 0.0006
615 RESPIRATORY TRACT CONGESTION 9 0.0006
616 RENAL PAIN 6 0.0006
617 SCIATICA 9 0.0006
618 TACHYCARDIA 50 0.0006
619 SENSORY DISTURBANCE 9 0.0006
620 HYPERHIDROSIS 72 0.0006
621 RHINORRHOEA 36 0.0006
622 DECREASED ACTIVITY 6 0.0006
623 BLOOD PRESSURE INCREASED 85 0.0006
624 FAECES DISCOLOURED 12 0.0006
625 MUSCLE ATROPHY 7 0.0006
626 TOOTHACHE 10 0.0006
627 CARDIOVASCULAR DISORDER 14 0.0006
628 MOOD ALTERED 15 0.0005
629 NEEDLE ISSUE 16 0.0005
630 APATHY 8 0.0005
631 DISEASE RECURRENCE 26 0.0005
632 THROMBOCYTOPENIA 61 0.0005
633 TOOTH FRACTURE 6 0.0005
634 OSTEOARTHRITIS 23 0.0005
635 TASTE DISORDER 11 0.0005
636 HIATUS HERNIA 7 0.0005
637 NERVE INJURY 6 0.0005
638 HEPATOTOXICITY 12 0.0005
639 CHEST DISCOMFORT 55 0.0005
640 COLON CANCER 8 0.0005
641 WOUND 15 0.0005
642 HYPOAESTHESIA 80 0.0005
643 PRODUCT DOSE OMISSION ISSUE 157 0.0005
644 ORAL CANDIDIASIS 7 0.0005
645 DYSARTHRIA 20 0.0005
646 HEART RATE IRREGULAR 12 0.0005
647 HALLUCINATION 40 0.0005
648 SARS-COV-2 TEST POSITIVE 7 0.0005
649 HYPOCALCAEMIA 10 0.0005
650 PULMONARY HYPERTENSION 11 0.0005
651 IMPAIRED DRIVING ABILITY 6 0.0005
652 GAIT DISTURBANCE 101 0.0005
653 BLOOD COUNT ABNORMAL 8 0.0005
654 RED BLOOD CELL COUNT DECREASED 15 0.0005
655 GASTROINTESTINAL DISORDER 47 0.0005
656 DEPRESSION 119 0.0005
657 WHEEZING 31 0.0005
658 PHARYNGEAL OEDEMA 8 0.0005
659 ARTHRALGIA 216 0.0005
660 MALIGNANT NEOPLASM PROGRESSION 53 0.0005
661 PSORIATIC ARTHROPATHY 21 0.0005
662 HERNIA 10 0.0005
663 RASH PRURITIC 28 0.0005
664 HEART RATE INCREASED 51 0.0005
665 INTENTIONAL PRODUCT MISUSE 45 0.0005
666 SPLENOMEGALY 6 0.0005
667 SKIN FISSURES 10 0.0005
668 LIP SWELLING 17 0.0005
669 LUNG DISORDER 25 0.0005
670 KIDNEY INFECTION 10 0.0005
671 DISCOMFORT 31 0.0005
672 SWELLING FACE 33 0.0005
673 JOINT SWELLING 61 0.0005
674 PRODUCT DISPENSING ERROR 11 0.0005
675 PROCEDURAL PAIN 14 0.0005
676 HAEMATOCRIT DECREASED 10 0.0005
677 BLADDER DISORDER 5 0.0005
678 CEREBRAL HAEMORRHAGE 18 0.0005
679 NECK PAIN 28 0.0005
680 BURNING SENSATION 35 0.0005
681 MOVEMENT DISORDER 16 0.0005
682 BLOOD TEST ABNORMAL 7 0.0005
683 THROMBOSIS 40 0.0005
684 PRODUCT PHYSICAL ISSUE 10 0.0005
685 LYMPHOPENIA 7 0.0005
686 ADRENAL INSUFFICIENCY 6 0.0005
687 PAIN IN JAW 14 0.0005
688 COGNITIVE DISORDER 23 0.0005
689 NIGHTMARE 17 0.0005
690 PSORIASIS 64 0.0005
691 RESPIRATORY DEPRESSION 6 0.0005
692 SUBDURAL HAEMATOMA 7 0.0005
693 MEMORY IMPAIRMENT 67 0.0005
694 MANIA 8 0.0005
695 CONJUNCTIVITIS 9 0.0005
696 EYE SWELLING 18 0.0005
697 PANCYTOPENIA 27 0.0005
698 VISUAL ACUITY REDUCED 16 0.0005
699 ERYTHEMA 99 0.0005
700 MALAISE 211 0.0005
701 PRODUCT USE IN UNAPPROVED INDICATION 119 0.0005
702 LEUKOPENIA 24 0.0005
703 INJECTION SITE PRURITUS 32 0.0005
704 DERMATITIS ALLERGIC 6 0.0005
705 PARAESTHESIA 75 0.0005
706 OROPHARYNGEAL PAIN 44 0.0005
707 SKIN LESION 13 0.0005
708 CIRCULATORY COLLAPSE 8 0.0005
709 IMMUNODEFICIENCY 7 0.0005
710 INTRAOCULAR PRESSURE INCREASED 6 0.0005
711 EXTRA DOSE ADMINISTERED 19 0.0005
712 DRUG PRESCRIBING ERROR 9 0.0005
713 PRURITUS 180 0.0005
714 THERAPY CESSATION 24 0.0005
715 SCAR 8 0.0005
716 COUGH 131 0.0005
717 IRRITABLE BOWEL SYNDROME 10 0.0005
718 DEMENTIA 13 0.0005
719 HYPOACUSIS 20 0.0005
720 PARANOIA 8 0.0005
721 LOWER RESPIRATORY TRACT INFECTION 21 0.0005
722 CHOKING 9 0.0005
723 ASTHMA 52 0.0005
724 BACK INJURY 5 0.0005
725 DEVICE FAILURE 7 0.0005
726 SINUSITIS 47 0.0005
727 BLOOD PRESSURE FLUCTUATION 11 0.0005
728 HAEMOGLOBIN DECREASED 47 0.0005
729 FEELING HOT 28 0.0005
730 INCORRECT PRODUCT STORAGE 6 0.0005
731 EOSINOPHILIA 8 0.0005
732 CARDIO-RESPIRATORY ARREST 19 0.0005
733 DYSPHAGIA 43 0.0005
734 RESPIRATORY FAILURE 33 0.0005
735 PULMONARY EMBOLISM 43 0.0005
736 NEUROPATHY PERIPHERAL 43 0.0005
737 EYE IRRITATION 26 0.0005
738 INSOMNIA 120 0.0005
739 INFECTION 65 0.0004
740 COLITIS 17 0.0004
741 CARDIAC ARREST 37 0.0004
742 CONDITION AGGRAVATED 136 0.0004
743 RASH PAPULAR 10 0.0004
744 BLOOD CALCIUM DECREASED 5 0.0004
745 SINUS CONGESTION 6 0.0004
746 NEUTROPHIL COUNT DECREASED 18 0.0004
747 RESTLESS LEGS SYNDROME 8 0.0004
748 ABSCESS 7 0.0004
749 OFF LABEL USE 382 0.0004
750 ANXIETY 124 0.0004
751 TREMOR 72 0.0004
752 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
753 INTENTIONAL DRUG MISUSE 9 0.0004
754 MYOCARDIAL INFARCTION 75 0.0004
755 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
756 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
757 MASS 6 0.0004
758 WITHDRAWAL SYNDROME 18 0.0004
759 KNEE ARTHROPLASTY 9 0.0004
760 VERTIGO 26 0.0004
761 CHILLS 50 0.0004
762 PHOTOPHOBIA 8 0.0004
763 CEREBROVASCULAR ACCIDENT 72 0.0004
764 ADVERSE EVENT 39 0.0004
765 GASTRIC ULCER 8 0.0004
766 LIMB DISCOMFORT 13 0.0004
767 POOR QUALITY SLEEP 9 0.0004
768 SKIN CANCER 9 0.0004
769 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
770 HAEMATOCHEZIA 23 0.0004
771 INJECTION SITE BRUISING 33 0.0004
772 OSTEOPOROSIS 17 0.0004
773 HEMIPARESIS 7 0.0004
774 PRODUCT PRESCRIBING ISSUE 9 0.0004
775 RASH 180 0.0004
776 DEVICE ISSUE 37 0.0004
777 C-REACTIVE PROTEIN INCREASED 15 0.0004
778 SOMNOLENCE 83 0.0004
779 NEURALGIA 10 0.0004
780 DYSPHONIA 24 0.0004
781 BONE PAIN 24 0.0004
782 FEELING ABNORMAL 98 0.0004
783 JAUNDICE 11 0.0004
784 ASCITES 12 0.0004
785 LIVER INJURY 10 0.0004
786 HEADACHE 255 0.0004
787 LABORATORY TEST ABNORMAL 12 0.0004
788 MULTI-ORGAN FAILURE 7 0.0004
789 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
790 TRANSAMINASES INCREASED 9 0.0004
791 PALLOR 11 0.0004
792 DEVICE DEFECTIVE 7 0.0004
793 VISUAL IMPAIRMENT 50 0.0004
794 FLUSHING 41 0.0004
795 CYST 5 0.0004
796 ALOPECIA 79 0.0004
797 UPPER LIMB FRACTURE 8 0.0004
798 THROAT IRRITATION 18 0.0004
799 PRESCRIBED UNDERDOSE 8 0.0004
800 RASH MACULAR 14 0.0004
801 BONE LOSS 6 0.0004
802 ILLNESS 41 0.0004
803 HEPATIC ENZYME INCREASED 27 0.0004
804 LYMPHOCYTE COUNT DECREASED 7 0.0004
805 IMPAIRED HEALING 13 0.0004
806 PRODUCT ADMINISTRATION ERROR 8 0.0004
807 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
808 EYE DISORDER 13 0.0004
809 HEAD DISCOMFORT 7 0.0004
810 BONE MARROW FAILURE 8 0.0004
811 SKIN EXFOLIATION 33 0.0004
812 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
813 MUSCLE TWITCHING 9 0.0004
814 INJECTION SITE PAIN 119 0.0004
815 ANGER 13 0.0004
816 BRAIN FOG 6 0.0004
817 IRRITABILITY 23 0.0004
818 DERMATITIS 8 0.0004
819 INCORRECT DOSE ADMINISTERED BY DEVICE 10 0.0004
820 ARRHYTHMIA 18 0.0004
821 HYPERSENSITIVITY 70 0.0004
822 BACTERIAL INFECTION 7 0.0004
823 EPISTAXIS 28 0.0004
824 LIVER FUNCTION TEST INCREASED 8 0.0004
825 MENTAL IMPAIRMENT 9 0.0004
826 SKIN DISCOLOURATION 17 0.0004
827 INJURY 26 0.0004
828 THROAT TIGHTNESS 10 0.0004
829 DRUG DOSE OMISSION 61 0.0004
830 INFLAMMATION 19 0.0004
831 PAIN 226 0.0004
832 METASTASES TO BONE 6 0.0004
833 POST PROCEDURAL COMPLICATION 7 0.0004
834 APHASIA 11 0.0004
835 CARDIAC DISORDER 34 0.0004
836 PHOTOSENSITIVITY REACTION 6 0.0004
837 STOMATITIS 22 0.0004
838 RESPIRATORY DISTRESS 10 0.0004
839 DERMATITIS ATOPIC 19 0.0004
840 EAR PAIN 7 0.0004
841 COORDINATION ABNORMAL 5 0.0004
842 OCULAR HYPERAEMIA 17 0.0004
843 SURGERY 21 0.0004
844 DRUG EFFECT INCOMPLETE 13 0.0004
845 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
846 NASAL CONGESTION 21 0.0004
847 SNEEZING 8 0.0004
848 DRUG INEFFECTIVE 470 0.0004
849 DEVICE MALFUNCTION 25 0.0004
850 INCORRECT DOSE ADMINISTERED 81 0.0004
851 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
852 NERVOUS SYSTEM DISORDER 11 0.0004
853 HOSPITALISATION 54 0.0004
854 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
855 TINNITUS 16 0.0003
856 INFUSION RELATED REACTION 23 0.0003
857 NEOPLASM PROGRESSION 12 0.0003
858 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 62 0.0003
859 PYREXIA 119 0.0003
860 UNEVALUABLE EVENT 26 0.0003
861 DEVICE USE ISSUE 6 0.0003
862 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
863 LUNG NEOPLASM MALIGNANT 14 0.0003
864 NASOPHARYNGITIS 62 0.0003
865 ISCHAEMIC STROKE 6 0.0003
866 PRODUCT USE ISSUE 63 0.0003
867 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
868 RESPIRATORY DISORDER 10 0.0003
869 DISEASE PROGRESSION 39 0.0003
870 PRESYNCOPE 8 0.0003
871 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
872 SUICIDAL IDEATION 30 0.0003
873 MUSCULOSKELETAL PAIN 17 0.0003
874 OSTEONECROSIS OF JAW 8 0.0003
875 FEMUR FRACTURE 10 0.0003
876 AGRANULOCYTOSIS 6 0.0003
877 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
878 THINKING ABNORMAL 6 0.0003
879 BLOOD CHOLESTEROL INCREASED 15 0.0003
880 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15 0.0003
881 DRUG INTOLERANCE 31 0.0003
882 DRY EYE 16 0.0003
883 DYSKINESIA 13 0.0003
884 CYANOSIS 5 0.0003
885 INFLUENZA LIKE ILLNESS 26 0.0003
886 MUSCULOSKELETAL DISORDER 6 0.0003
887 DISTURBANCE IN ATTENTION 17 0.0003
888 STEVENS-JOHNSON SYNDROME 7 0.0003
889 THERAPEUTIC RESPONSE DECREASED 19 0.0003
890 DRUG RESISTANCE 8 0.0003
891 PRODUCT QUALITY ISSUE 42 0.0003
892 RASH GENERALISED 8 0.0003
893 DIPLOPIA 8 0.0003
894 PLASMA CELL MYELOMA 12 0.0003
895 DEAFNESS 8 0.0003
896 ARTHROPATHY 17 0.0003
897 ECZEMA 16 0.0003
898 SPEECH DISORDER 16 0.0003
899 DEATH 263 0.0003
900 ABNORMAL BEHAVIOUR 12 0.0003
901 TREATMENT FAILURE 25 0.0003
902 ACCIDENTAL OVERDOSE 11 0.0003
903 ADVERSE DRUG REACTION 27 0.0003
904 RHEUMATOID ARTHRITIS 34 0.0003
905 EYE PRURITUS 10 0.0003
906 FEAR 8 0.0003
907 ILL-DEFINED DISORDER 18 0.0003
908 BLOOD BILIRUBIN INCREASED 8 0.0003
909 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 60 0.0003
910 EPILEPSY 9 0.0003
911 SEIZURE 34 0.0003
912 PRODUCT PRESCRIBING ERROR 7 0.0003
913 INJECTION SITE RASH 9 0.0003
914 RASH ERYTHEMATOUS 14 0.0003
915 DEVICE DELIVERY SYSTEM ISSUE 8 0.0003
916 HEPATIC CANCER 7 0.0003
917 HAEMORRHAGE 30 0.0003
918 FEBRILE NEUTROPENIA 19 0.0003
919 MUSCULOSKELETAL STIFFNESS 25 0.0003
920 INJECTION SITE URTICARIA 7 0.0003
921 MOUTH ULCERATION 6 0.0003
922 DRY SKIN 38 0.0003
923 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
924 COLD SWEAT 5 0.0003
925 LYMPHADENOPATHY 10 0.0003
926 EXTRAPYRAMIDAL DISORDER 7 0.0003
927 PRURITUS GENERALISED 6 0.0003
928 RESTLESSNESS 10 0.0003
929 COMA 13 0.0003
930 ANAPHYLACTIC SHOCK 7 0.0003
931 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
932 EXPIRED PRODUCT ADMINISTERED 9 0.0003
933 HAEMATOMA 7 0.0003
934 NEOPLASM MALIGNANT 18 0.0003
935 RESPIRATORY TRACT INFECTION 7 0.0003
936 NERVOUSNESS 14 0.0003
937 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
938 SEDATION 7 0.0003
939 DEPRESSED MOOD 14 0.0003
940 PRODUCT AVAILABILITY ISSUE 6 0.0003
941 AMNESIA 17 0.0003
942 AGITATION 19 0.0003
943 ABNORMAL DREAMS 7 0.0003
944 MENTAL DISORDER 11 0.0003
945 INJECTION SITE ERYTHEMA 31 0.0002
946 PROSTATE CANCER 20 0.0002
947 TARDIVE DYSKINESIA 7 0.0002
948 PANIC ATTACK 9 0.0002
949 DEEP VEIN THROMBOSIS 16 0.0002
950 ABASIA 6 0.0002
951 PRODUCT STORAGE ERROR 21 0.0002
952 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
953 RECTAL HAEMORRHAGE 10 0.0002
954 INJECTION SITE REACTION 16 0.0002
955 HEPATIC FAILURE 7 0.0002
956 MUCOSAL INFLAMMATION 6 0.0002
957 EMOTIONAL DISORDER 7 0.0002
958 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 16 0.0002
959 BREAST CANCER FEMALE 6 0.0002
960 COLITIS ULCERATIVE 10 0.0002
961 DRUG EFFECT DECREASED 12 0.0002
962 FOETAL EXPOSURE DURING PREGNANCY 18 0.0002
963 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
964 ANAPHYLACTIC REACTION 12 0.0002
965 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
966 VIRAL INFECTION 7 0.0002
967 RENAL CANCER 10 0.0002
968 MIGRAINE 20 0.0002
969 INJECTION SITE SWELLING 16 0.0002
970 EMOTIONAL DISTRESS 25 0.0002
971 BREAST CANCER 17 0.0002
972 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
973 SKIN DISORDER 6 0.0002
974 DISORIENTATION 7 0.0002
975 MYELOSUPPRESSION 6 0.0002
976 BONE DENSITY DECREASED 5 0.0002
977 OVERDOSE 34 0.0002
978 NO ADVERSE EVENT 28 0.0002
979 SKIN IRRITATION 7 0.0002
980 DRUG ABUSE 12 0.0001
981 CONVULSION 8 0.0001
982 VAGINAL HAEMORRHAGE 6 0.0001
983 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
984 EXPOSURE DURING PREGNANCY 8 0.0001
985 DRUG WITHDRAWAL SYNDROME 11 0.0001
986 AGGRESSION 6 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
988 DEVICE DIFFICULT TO USE 7 0.0001
989 DRUG DOSE OMISSION BY DEVICE 8 0.0001
990 ACNE 7 0.0001
991 SKIN BURNING SENSATION 6 0.0001
992 DRUG DEPENDENCE 12 0.0001